Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Neste, Leander" or (type any "bookEditor issueEditor" and editor="Van Neste, Leander")

Add to list
- Conference Paper
- C3
Ability of an epigenetic assay to identify anterior prostate tumors based on a negative 12-core biopsy

Todd Matthew Morgan, Simpa Samuel Salami, John Thomas Wei, Ganesh S Palapattu, Amy Gursky, Wim Van Criekinge (UGent) , Leander Van Neste and Rohit Mehra

(2016) JOURNAL OF CLINICAL ONCOLOGY. 34(2, suppl.).
Add to list
- Conference Paper
- C3
Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease

Leander Van Neste, Grant Stewart, Sandra Marlene Gaston, William E Grizzle, George W Adams, Gary P Kearney, Jonathan I Epstein, David James Harrison, Alan W Partin and Wim Van Criekinge (UGent)

(2016) In JOURNAL OF CLINICAL ONCOLOGY 34(2, suppl.).
Add to list
Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score

Leander Van Neste, Rianne J Hendriks, Siebren Dijkstra, Geert Trooskens (UGent) , Erik B Cornel, Sander A Jannink, Hans de Jong, Daphne Hessels, Frank P Smit, Willem JG Melchers, et al.

(2016) EUROPEAN UROLOGY. 70(5). p.740-748
Add to list
We are all individuals...: bioinformatics in the personalized medicine era

Leander Van Neste and Wim Van Criekinge (UGent)

(2015) CELLULAR ONCOLOGY. 38(1). p.29-37
Add to list
- Conference Paper
- C3
Risk stratification of aggressive prostate cancer based on combined epigenetic and clinical data of men with initial cancer-negative biopsies

Alan W Partin, Leander Van Neste, Grant D Stewart, Joseph Bigley, David J Harrison, Wim Van Criekinge (UGent) and Jonathan I Epstein

(2015) JOURNAL OF UROLOGY. 193(4, suppl.). p.E959-E960
Add to list
- Conference Paper
- C3
Epigenetic assay stratifies prostate cancer patients' risk for aggressiveness

Leander Van Neste, Wim Van Criekinge (UGent) , Joseph Bigley, William E Grizzle, George W Adams, Gary P Kearney and Sandra M Gaston

(2015) JOURNAL OF UROLOGY. 193(4, suppl.). p.E58-E59
Add to list
Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 are promising markers for the detection of colorectal cancer in blood

Veerle Melotte, Joo Mi Yi, Marjolein HFM Lentjes, Kim M Smits, Leander Van Neste, Hanneke EC Niessen, Kim AD Wouters, Joost Louwagie, Kornel E Schuebel, James G Herman, et al.

(2015) CANCER PREVENTION RESEARCH. 8(2). p.157-164
Add to list
- Conference Paper
- C3
Epigenetic profiling of prostate cancer tissue to identify men with high-risk disease

Leander Van Neste, Jeffrey Falk, Ming-Chou Lee, Joseph Bigley, Wim Van Criekinge (UGent) and E David Crawford

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(4, suppl.).
Add to list
- Conference Paper
- C3
Evaluation of different methods to assess homologous recombination status and sensitivity to PARP inhibitors in ovarian cancer

A Mukhopadhyay, M Dixon, E Mulligan, H Schuhwerk, J Murray, J Quinn, Leander Van Neste (UGent) , Wim Van Criekinge (UGent) , N Curtin and R Edmondson

(2014) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 24(9, suppl. 4). p.353-354
Add to list
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies

Alan W Partin, Leander Van Neste, Eric A Klein, Leonard S Marks, Jason R Gee, Dean A Troyer, Kimberly Rieger-Christ, J Stephen Jones, Cristina Magi-Galluzzi, Leslie A Mangold, et al.

(2014) JOURNAL OF UROLOGY. 192(4). p.1081-1087

← Previous

Academic Bibliography

Ability of an epigenetic assay to identify anterior prostate tumors based on a negative 12-core biopsy

Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease

Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score

We are all individuals...: bioinformatics in the personalized medicine era

Risk stratification of aggressive prostate cancer based on combined epigenetic and clinical data of men with initial cancer-negative biopsies

Epigenetic assay stratifies prostate cancer patients' risk for aggressiveness

Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 are promising markers for the detection of colorectal cancer in blood

Epigenetic profiling of prostate cancer tissue to identify men with high-risk disease

Evaluation of different methods to assess homologous recombination status and sensitivity to PARP inhibitors in ovarian cancer

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies

Contents

Support

Contact